SPINK1 and cancer: As SPINK1 is subject to frequent overexpression, mutation, amplification, and deep deletion in cancer patients as revealed by the TCGA genomics data (Fig. 7g–i), SPINK1 is considered as a potential predictor of disease progression in treatment-naive patients40,41.